Journal of Pediatric Cardiology and Cardiac Surgery

Online ISSN: 2433-1783 Print ISSN: 2433-2720
Japanese Society of Pediatric Cardiology and Cardiac Surgery
Japanese Society of Pediatric Cardiology and Cardiac Surgery Academy Center, 358-5 Yamabuki-cho, Shinju-ku, Tokyo 162-0801, Japan
Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Case ReportCase Report

Ventricular Fibrillation in a Family with Short QT Syndrome Type 2 Carrying a Heterozygous KCNQ1-V141M Variant

1Department of Pediatrics, Chiba Cerebral and Cardiovascular Center ◇ Ichihara, Japan

2Department of Cardiovascular Medicine, Shiga University of Medical Science ◇ Otsu, Japan

3Department of Community Medicine Supporting System, Kyoto University Graduate School of Medicine ◇ Kyoto, Japan

4Department of Bioscience and Genetics, Cerebral and Cardiovascular Center ◇ Suita, Japan

5Department of Cardiovascular Surgery, Chiba Cerebral and Cardiovascular Center ◇ Ichihara, Japan

6Department of Cardiovascular Surgery, Chiba, Kaihin Municipal Hospital ◇ Chiba, Japan

7Department of Pediatrics, Chiba Kaihin Municipal Hospital ◇ Chiba, Japan

受付日:2021年7月1日Received: July 1, 2021
受理日:2021年9月10日Accepted: September 10, 2021
発行日:2022年1月31日Published: January 31, 2022

Short QT syndrome (SQTS) is an inheritable cardiac electrical disease presenting both atrial and ventricular arrhythmias associated with abnormally short QT intervals on electrocardiograms (ECGs). SQTS is mainly associated with mutations of the genes encoding three different cardiac potassium channels. Among them, type 2 SQTS (SQT2) can be caused by gain-of-function of KCNQ1, resulting in accelerating ventricular repolarization. Several studies reported that patients with SQT2 bearing the KCNQ1 c.421G>A: p.V141M variant occasionally suffered from atrial fibrillation or bradycardia but rarely developed ventricular arrhythmias, and thus the variant has been considered as benign. However, when we observed an SQT2 family with the KCNQ1 p.V141M variant, one of the family members had developed ventricular fibrillation. The proband was referred to our hospital due to severe bradycardia (atrial standstill) and short QT intervals at the age of two and received a pacemaker implantation (PMI) using epicardial ventricular leads. The proband’s father also underwent a PMI at the age of 20 due to sick sinus syndrome. Genetic testing, performed to investigate familial bradycardia, identified a heterozygous KCNQ1 p.V141M variant in the proband and the father. Since the PMI, the father had been stable until at the age of 42 when he had a syncope due to ventricular fibrillation (VF). The VF was successfully terminated by an automated external defibrillator, and an implantable cardioverter-defibrillator was implanted. This is the first reported case of a patient with SQT2 bearing the KCNQ1 p.V141M variant showing lethal ventricular arrhythmia.

Key words: fetal bradycardia; short QT; sick sinus syndrome; ventricular fibrillation; ICD


The short QT syndrome (SQTS) is an inheritable cardiac electrical disease characterized by remarkably shortened QT intervals which creates electrical substrates for atrial and ventricular arrhythmias. Though it was first reported by Gussak et al. in 2000,1) its natural history and risk stratification remain unclear due to its rarity. Though six genes have been reported causative of SQTS, it mainly results from gain-of-function mutations in the potassium channel genes. They are classified into three subtypes, SQT1, SQT2 and SQT3, depending on the associated genes, KCNH2, KCNQ1, and KCNJ2, respectively.2–4)

Among these three genes, KCNQ1 encodes the alpha-subunit of slowly-activating delayed rectifier potassium channel (IKs). To date, six KCNQ1 variants have been reported in SQT2: p.V307L2), p.V141M,5) p.I274V,6) p.F279I,7) p.R259H,8) and p.A287T.9) Patients, except those bearing the p.V141M variant, often show lethal arrhythmias. In contrast, the phenotypes of SQT2 caused by the p.V141M variant differ from the others in that most patients occasionally suffer from atrial fibrillation (AF) or severe bradycardia but rarely develop ventricular arrhythmias.5, 10–12)

We herein report an unusual case of a family bearing the KCNQ1 p.V141M variant. The proband showed early onset bradycardia, and the proband’s father developed ventricular fibrillation (VF) in addition to long-term sick sinus syndrome (SSS). Our observation questions the classification of p.V141M as a benign variant and requires reconsideration of the therapeutic strategy in the treatment of patients bearing this variant.

Case 1: Proband

A two-year-old male was referred to our hospital to indicate the necessity of a pacemaker implantation (PMI). The following measurements were taken at this visit: height, 87.4 cm; weight, 12.4 kg; heart rate, 50 beats per minute (bpm); and blood pressure, 81/49 mmHg. He showed no objective findings of heart failure. There were no audible rales nor cardiac murmurs. His chest X-ray showed an increased cardiothoracic ratio (CTR) of 62% without pulmonary congestion (Fig. 1A). Upon reviewing his birth history, at the gestational age of 24 weeks, he presented bradycardia with a heart rate of 80 bpm, and by 35 weeks, his heart rate decreased to 55 bpm. He was diagnosed with SSS and patent ductus arteriosus (PDA) at birth. His father also underwent a PMI at the age of 20 due to bradycardia that had been occurring since infancy.

Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Fig. 1 Chest X-ray of the proband

A: Before pacemaker implantation. B: After pacemaker implantation. CTR, cardiothoracic ratio.

His 12-lead electrocardiogram (ECG) (Fig. 2A) showed atrial standstill with junctional rhythm at a rate of 50 bpm and short QT intervals (QTc: 308 ms by Bazett formula and 315 ms by Fridericia formula). His Holter monitoring showed that total heart beats were 69,445 beats per day with a minimum heart rate of 29 bpm and a max R-R interval of 3.04 second. His transthoracic echocardiography showed that the left ventricular ejection fraction was within normal range (68%) but the left ventricular end-diastolic volume increased to 193% of the normal values. His computed tomography with contrast materials revealed a small PDA with the narrowest portion with a diameter of <1 mm. The shunt flow of the PDA was clinically negligible, and we concluded that the persistent bradycardia caused cardiomegaly. An electrophysiological study along with a PMI was planned under general anesthesia.

Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Fig. 2 Electrocardiogram (ECG) of the proband

A: An ECG recorded at our hospital showed junctional rhythm at a rate of 50 bpm and short QT-intervals (QTc: 308 ms by Bazett formula and 315 ms by Fridericia formula). B: An ECG after pacemaker implantation. All beats were ventricular pacing. ECG, electrocardiogram.

During the operation, an intravenous injection of atropine sulfate induced a narrow QRS tachycardia. Its R-R intervals were irregular, with a range from 100 to 200 bpm, and no P waves nor atrial fibrillation waves were detected, indicating a diagnosis of junctional tachycardia (data not shown). Under the left thoracotomy for the PMI, we couldn’t obtain any atrial electrograms and observed no atrial contractions (i.e., atrial standstill). Maximum output of electrical stimulation failed to pace the atrium, thus only ventricular leads were sutured at left ventricular apex. The pacing mode was VVI, and lower rate was programmed at 80 bpm. After the PMI, cardiomegaly improved; the CTR decreased to 57% (Fig. 1B). The amount of ventricular pacing was 99%, and none of his own beats were detected by a 12-lead ECG after the PMI (Fig. 2B). The proband is now 7 years old and presents no ventricular arrhythmias thus far.

Genetic Analysis

Genetic studies were approved by the Medical Ethical Committee of the Shiga University of Medical Science (IRB reference number G2011-128), and informed consents were obtained while preserving the anonymity of the patients. After obtaining informed consents, we performed a genetic analysis of the proband for investigation of familial bradycardia and short QT intervals using a gene panel test targeting 60 arrhythmia-related genes, HaloPlex Custom Kits (Agilent, Santa Clara, CA, USA). As a result, a KCNQ1 heterozygous missense variant c.421G>A:p.V141M (rs199472687), located in the transmembrane segment 1, was detected. The variant was confirmed by Sanger methods, and his father was also found to carry the same variant by Sanger sequencing (Fig. 3). It was not identified in the proband’s asymptomatic mother (Fig. 3), and it was not identified in the general population (gnomAD v.2.1.1.).

Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Fig. 3 Genetic analysis

A: A pedigree of the family with SQTS. The arrow depicts the proband; +, variant carrier; −, non carrier. B: Electropherograms of the Sanger sequence. A nucleotide substitution of G to A was observed in the proband and his father. SQTS, short QT syndrome.

Case 2: Proband’s Father

The proband’s father was shown to have bradycardia and diagnosed with multifocal atrial tachycardia in his infancy. At the age of eight, an electrophysiological study revealed atrial standstill, and at the age of 20, he underwent a transvenous PMI. The ventricular lead was located at right ventricular apex. His previous ECG obtained at the age of 18 showed SSS with irregular junctional rhythm and very short QT intervals (QTc: 293 ms by Bazett formula and 302 ms by Fridericia formula; Fig. 4). He underwent a genetic analysis triggered by his son’s PMI (result as above).

Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Fig. 4 Electrocardiogram of proband’s father at 18 years old

The QT intervals (average values of three beats) were short (QTc: 293 ms by Bazzett formula and 302 ms by Fridericia formula).

After the PMI, he had been asymptomatic and ventricular arrhythmias were not documented. The pacing mode was VVI, and lower-rate was programmed at 50 bpm. The amount of his ventricular pacing was about 20%, and based on his rate histogram, his heart rate didn’t exceed 130 bpm often. However, at the age of 42, he had a syncopal attack and collapsed on exercise. He was resuscitated by an automated external defibrillator (AED), and the ECG trace stored in the AED showed VF (Fig. 5A). Intracardiac ECG stored in his pacemaker also showed ventricular tachy-event before the shock (Fig 5B). When he was transferred to our hospital, he was conscious and stable (pulse rate: irregular at 66 bpm; and blood pressure:136/78 mmHg). His height and weight were 161 cm and 105 kg, respectively (BMI 40.5). No rales nor cardiac murmurs were audible. His 12-lead ECG showed atrial standstill with irregular and slow junctional beats with occasional ventricular pacing. The QT intervals were 325 ms by Bazett formula and 319 ms by Fridericia formula measured at junctional beats (Fig. 5C). His computed tomography with contrast materials did not detect any significant coronary arterial stenosis, and his blood examination was void of abnormal electrolytes and myocardial damages. Since his VF was not associated with correctable conditions such as cardiac ischemia and electrolyte disturbances, he received an implantable cardioverter-defibrillator (ICD). In the past two years since the implantation, no ICD shocks were discharged.

Journal of Pediatric Cardiology and Cardiac Surgery 6(1): 31-36 (2022)

Fig. 5 Electrocardiogram (ECG) of proband’s father

A: Ventricular fibrillation (VF) detected by automated external defibrillator; the VF was successfully terminated by a DC shock. B: Intracardiac ECG stored in his pacemaker also showed ventricular tachy-event before the shock. C: A 12-lead ECG recorded on admission showed atrial standstill with junctional beats at a rate of 66 bpm and occasional ventricular pacing. The QT intervals were short (QTc: 325 ms by Bazett formula and 319 ms by Fridericia formula). ECG, electrocardiogram; VF, ventricular fibrillation.


In the current study, we report a family with SQT2 bearing the heterozygous KCNQ1 p.V141M variant. Main clinical features of the family were atrial standstill with irregular junctional rhythm manifesting a very early onset bradycardia (i.e. SSS) and documented VF in the proband’s father. Among six KCNQ1 variants associated with SQT2, only the p.V141M variant was reportedly not associated with lethal ventricular arrhythmias.5, 10–12) The KCNQ1 p.V307L variant was reported by Bellocq et al.2) In that report, the proband was a 70-year-old man who survived a VF. Rhodes et al.6) identified the KCNQ1 p. I274V variant in a patient who suffered from sudden infant death syndrome, and its functional assay showed a gain-of-function effect, shortening ventricular action potential durations.

Lee et al.13) demonstrated that the p.V141M variant had also shortened ventricular action potentials and enhanced transmural action potential duration heterogeneity in the presence of β-adrenergic stimulation, which may lead to short refractory periods and formation of functional reentrant circuits. However, to date, no lethal ventricular arrhythmias have ever been reported in SQT2 patients with the KCNQ1 p.V141M variant as stated by Bjerregaard,10) but these patients are susceptible to AF and early onset bradycardia such as SSS.

It couldn’t be stated unconditionally that KCNQ1 p.V141M variant was absolute cause of VF, because the mechanism of VF in the proband’s father was unclear. Nevertheless, we thought this episode, that is, the proband’s father in the current study developed a VF raised an important alarm for the treatment of patients with this KCNQ1 variant. As there is some possibility that this variant causes a VF, we should carefully monitor and follow-up with the proband, even though his bradycardia had been treated by a cardiac pacemaker. Considering the VF in his father, an ICD may need to be implanted for the proband. However, currently, ICD implantation as a primary prevention in patients with SQTS bearing the KCNQ1 p.V141M variant is controversial because there is little evidence of risk stratification due to a small number of cases and lack of prospective randomized studies.

To assess prognostic risks in SQTS patients who were younger than 21-years-old, Villafane et al.14) reported that those who showed >5 points of Modified Gollob scores tended to suffer from ventricular arrhythmias though it is still controversial.8) Giustetto et al.15) implanted ICDs in the cases who had family history of sudden cardiac death or who showed inducible VF by EPS as a primary prevention. Though appropriate shocks were delivered, frequent inappropriate shocks or ICD-related complications were also observed. As for the medical treatment for this family, quinidine and sotalol that block rapidly-activating delayed rectifier potassium channels (IKr) should be considered.


To the best of our knowledge, this is the first reported case of a family with SQT2 bearing the KCNQ1 p.V141M variant with a family member who had aborted sudden cardiac death due to ventricular fibrillation. The arrhythmia phenotypes in our case were atypical compared to previously reported cases.


automated external defibrillator
atrial fibrillation
cardiothoracic ratio
implantable cardioverter-defibrillator
patent ductus arteriosus
pacemaker implantation
short QT syndrome
sick sinus syndrome
ventricular fibrillation

Conflicts of Interest

The authors have no conflicts of interest to disclose.


1) Gussak I, Brugada P, Brugada J, et al: Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000; 94: 99–102

2) Bellocq C, van Ginneken AC, Bezzina CR, et al: Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004; 109: 2394–2397

3) Brugada R, Hong K, Dumaine R, et al: Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30–35

4) Priori SG, Pandit SV, Rivolta I, et al: A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005; 96: 800–807

5) Hong K, Piper DR, Diaz-Valdecantos A, et al: De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005; 68: 433–440

6) Rhodes TE, Abraham RA, Welch RC, et al: Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol 2008; 44: 571–581

7) Moreno C, Oliveras A, de la Cruz A, et al: A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome. Cardiovasc Res 2015; 107: 613–623

8) Mazzanti A, Kanthan A, Monteforte N, et al: Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol 2014; 63: 1300–1308

9) Rothenberg I, Piccini I, Wrobel E, et al: Structural interplay of KV7.1 and KCNE1 is essential for normal repolarization and is compromised in short QT syndrome 2 (KV7.1-A287T). HeartRhythm Case Rep 2016; 2: 521–529

10) Bjerregaard P: Diagnosis and management of short QT syndrome. Heart Rhythm 2018; 15: 1261–1267

11) Harrell DT, Ashihara T, Ishikawa T, et al: Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome. Int J Cardiol 2015; 190: 393–402

12) Villafane J, Fischbach P, Gebauer R: Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia. Cardiology 2014; 128: 236–240

13) Lee HC, Rudy Y, Liang H, et al: Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling. J Med Biol Eng 2017; 37: 780–789

14) Villafane J, Atallah J, Gollob MH, et al: Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 2013; 61: 1183–1191

15) Giustetto C, Schimpf R, Mazzanti A, et al: Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011; 58: 587–595

This page was created on 2022-01-07T14:32:53.106+09:00
This page was last modified on 2022-01-26T15:39:15.000+09:00